These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30007947)
1. Research priority setting by young people with rheumatic musculoskeletal disease. McDonagh JE; Lunt L; Cresswell K; Parsons S; Tattersall R; Arch Dis Child; 2019 Feb; 104(2):204. PubMed ID: 30007947 [No Abstract] [Full Text] [Related]
2. What do young people with rheumatic disease believe to be important to research about their condition? A UK-wide study. Parsons S; Thomson W; Cresswell K; Starling B; McDonagh JE; Pediatr Rheumatol Online J; 2017 Jul; 15(1):53. PubMed ID: 28673355 [TBL] [Abstract][Full Text] [Related]
3. What do young people with rheumatic conditions in the UK think about research involvement? A qualitative study. Parsons S; Thomson W; Cresswell K; Starling B; McDonagh JE; Pediatr Rheumatol Online J; 2018 May; 16(1):35. PubMed ID: 29793489 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of musculoskeletal pain and rheumatic diseases in the southeastern region of Mexico. A COPCORD-based community survey. Alvarez-Nemegyei J; Peláez-Ballestas I; Sanin LH; Cardiel MH; Ramirez-Angulo A; Goycochea-Robles MV J Rheumatol Suppl; 2011 Jan; 86():21-5. PubMed ID: 21196595 [TBL] [Abstract][Full Text] [Related]
5. Health planning in rheumatic diseases. Elaboration of a master plan for rheumatic and musculoskeletal diseases of Catalonia. Larrosa M; Surís X; Pueyo MJ; Auleda J; de la Puente ML Reumatol Clin; 2012; 8(2):72-7. PubMed ID: 22341527 [TBL] [Abstract][Full Text] [Related]
6. [Germany's largest healthcare study NAKO with musculoskeletal examination program has started]. Günther KP; Sander O; Schmidt CO; Specker C; Zink A Z Rheumatol; 2016 Oct; 75(8):757-759. PubMed ID: 27312469 [No Abstract] [Full Text] [Related]
7. Setting research priorities to improve the health of children and young people with neurodisability: a British Academy of Childhood Disability-James Lind Alliance Research Priority Setting Partnership. Morris C; Simkiss D; Busk M; Morris M; Allard A; Denness J; Janssens A; Stimson A; Coghill J; Robinson K; Fenton M; Cowan K BMJ Open; 2015 Jan; 5(1):e006233. PubMed ID: 25631309 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology. Courage UU; Stephen DP; Lucius IC; Ani C; Oche AO; Emmanuel AI; Olufemi AO Clin Rheumatol; 2017 Nov; 36(11):2509-2516. PubMed ID: 28447235 [TBL] [Abstract][Full Text] [Related]
10. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases. Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of musculoskeletal disorders in southeastern Iran: a WHO-ILAR COPCORD study (stage 1, urban study). Sandoughi M; Zakeri Z; Tehrani Banihashemi A; Davatchi F; Narouie B; Shikhzadeh A; Mohammadi M; Jahantigh M; Shakiba M; Moulaei NA; Yousefi S; Rezazehi B; Shirzaei Sani E; Emamdadi A; Hoseynian M; Masoodian S; Shahbakhsh S Int J Rheum Dis; 2013 Oct; 16(5):509-17. PubMed ID: 24164837 [TBL] [Abstract][Full Text] [Related]
12. Musculoskeletal disorders--disease burden and challenges in the developing world. Gcelu A; Kalla AA S Afr Med J; 2015 Dec; 105(12):1070-1. PubMed ID: 26933718 [No Abstract] [Full Text] [Related]
13. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches. Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward? Kitas GD; Dimitroulas T Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989 [No Abstract] [Full Text] [Related]
15. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Chopra A; Abdel-Nasser A Best Pract Res Clin Rheumatol; 2008 Aug; 22(4):583-604. PubMed ID: 18783739 [TBL] [Abstract][Full Text] [Related]
16. [Not Available]. Burmester GR Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S2. PubMed ID: 26536183 [No Abstract] [Full Text] [Related]
17. The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study. World Health Organization. International League of Associations for Rheumatology. Community Oriented Programme for the Control of the Rheumatic Diseases. Dans LF; Tankeh-Torres S; Amante CM; Penserga EG J Rheumatol; 1997 Sep; 24(9):1814-9. PubMed ID: 9292809 [TBL] [Abstract][Full Text] [Related]
18. [Not Available]. Strangfeld A Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S3-4. PubMed ID: 26536188 [No Abstract] [Full Text] [Related]
19. Successful implementation of a clinical transition pathway for adolescents with juvenile-onset rheumatic and musculoskeletal diseases. Walter M; Kamphuis S; van Pelt P; de Vroed A; Hazes JMW Pediatr Rheumatol Online J; 2018 Aug; 16(1):50. PubMed ID: 30075795 [TBL] [Abstract][Full Text] [Related]
20. Providing Rheum with a View. Mandell BF Med Clin North Am; 2021 Mar; 105(2):xv-xvi. PubMed ID: 33589112 [No Abstract] [Full Text] [Related] [Next] [New Search]